We reported that serum GP73 is closely related to the severity of liver necroinflammation and has the potential to identify moderate to severe liver necroinflammation in patients with either chronic hepatitis B virus infection or nonalcoholic steatohepatitis (NASH) [16–18]. The gene discussed is GOLM1; the disease is metabolic dysfunction-associated steatohepatitis.